Orchid Pharma Ltd.

Financial

	Orchid Pharma	Sequent Scientific	Unichem Lab
Operational Metrics
Financials
5 yr Average ROE	-4.13 %	1.28 %	-2.21 %
5yr average Equity Multiplier	1.73	2.12	1.28
5yr Average Asset Turnover Ratio	0.45	0.92	0.42
5yr Avg Net Profit Margin	-7.02 %	0.94 %	-3.85 %
Price to Book	3.5	5.67	1.88
P/E	38.82	330.58	0.0
5yr Avg Cash Conversion Cycle	49.11 Days	55.84 Days	80.33 Days
Inventory Days	112.59 Days	76.26 Days	146.44 Days
Days Receivable	91.49 Days	87.51 Days	128.35 Days
Days Payable	201.52 Days	117.98 Days	225.53 Days
5yr Average Interest Coverage Ratio	-0.51	2.31	-0.08
5yr Avg ROCE	0.51 %	7.29 %	-0.47 %
5yr Avg Operating Profit Margin	10.69 %	8.58 %	2.2 %
5 yr average Debt to Equity	0.49	0.5	0.09
5yr CAGR Net Profit	n/a	n/a	3.21 %
5yr Average Return on Assets	-1.77 %	0.71 %	-1.68 %
Shareholdings
Promoter Holding	69.84 %	52.61 %	70.22 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-20.16 %	-0.41 %	19.29 %
Change in Mutual Fund Holding (3 Yrs)	16.34 %	9.92 %	1.71 %

Business

	Orchid Pharma	Sequent Scientific	Unichem Lab
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 76.42 Sterile 23.58 Active Pharmaceutical Ingredient 0 Formulations 0 Bulk Drugs and chemicals 0	Product Wise Break-Up Sterile 0 Active Pharmaceutical Ingredient (API) 21.13 Formulations 78.27 Oral Formulations 0 Bulk Drugs and chemicals 0 Others 0.6	Product Wise Break-Up Sterile 0 Active Pharmaceutical Ingredient 0 Formulations 91.7 Oral Formulations 0 Bulk Chemicals 8.3
Location Wise Break-Up	Location Wise Break-Up India 18.32 Turkey 0 LATAM 0 EM 0 Rest of the World 0 Asia 0 Europe 0 USA 0 Others 81.68	Location Wise Break-Up EM 0 India 0 Turkey 0 Asia Pacific 24.1 USA 0 Rest of the World 34.17 Europe 41.73 LATAM 0	Location Wise Break-Up EM 0 India 2.47 Turkey 0 Asia 0 USA 60.68 Rest of the World 0 Europe 0 LATAM 0 Others 36.85
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-